Growth hormone

Tesamorelin

An approved medicine for a specific indication. This listing is not a prescription or a dosing guide.

A growth hormone-releasing factor analogue with an established medical use for reducing excess abdominal visceral fat in certain adults with HIV-associated lipodystrophy. It is not a general weight-loss treatment.

Vial size

CA$110

Estimated retail midpoint, CAD

• Code BC-13
• Form Research vial
• Category Growth hormone

Research-use only. Not for human or veterinary administration. Availability depends on applicable regulations, including in Canada. Prices are estimates, not verified market averages. Descriptions are informational and do not imply Health Canada approval or proven clinical effectiveness. Many listed compounds are investigational or not authorized for human use in Canada.